Effect of , 25 Dihydroxy-vitamin on Bone Resolution in Complete Freund's Adjuvant-induced Osteoporotic Rats |
김주영
(충북대학교 수의과대학)
강성수 (전남대학교 수의과대학) 김소섭 (충북대학교 수의과대학) 최석화 (충북대학교 수의과대학) 배춘식 (전남대학교 수의과대학) |
1 |
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease
/
DOI ScienceOn |
2 |
Therapeutic effects of 1α,25 dihydroxycholecalciferol on osteoporotic fracture in a rat model
/
|
3 |
Intravenous pamidronate as treatment for osteoporosis after heart transplantation : a prospective study
/
DOI ScienceOn |
4 |
Male osteoporosis
/
|
5 |
The effect of <TEX>$1,25(OH)_2D_3$</TEX> on bone mineral content in senile osteoporosis-A dose finding study
/
|
6 |
Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxy- cholecalciferol
/
DOI ScienceOn |
7 |
Heparin-induced osteoporosis
/
|
8 |
Calcitonin
/
DOI ScienceOn |
9 |
1,25 dihydroxyvitamin D3 stimulates alkaline phosphatase activity and inhibits soft tissue proliferation in implants of bone matrix
/
|
10 |
Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency
/
DOI ScienceOn |
11 |
Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate
/
|
12 |
Bone change in rats with adjuvant arthritis : treatment with 1α-hydroxycholecalciferol
/
|
13 |
1,25 dihydroxyvitamin <TEX>$D_3$</TEX> as well as its analogue OCT lower blood calcium through inhibition of bone resortion in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion
/
DOI ScienceOn |
14 |
Short-term prophylaxis against estrogen depletion-induced bone loss with calcitrol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized reats
/
DOI ScienceOn |
15 |
Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis
/
|
16 |
Time course of femoral neck osteopenia in ovariectomized rats
/
DOI ScienceOn |
17 |
Calcitriol for postmenopausal osteoporosis
/
|
18 |
New treatment strategies: ipriflavone, strontium, vitamin D metabolites and analogs
/
DOI |
19 |
The role of fluoride in the prevention of osteoporosis
/
DOI ScienceOn |
20 |
Fast and slow bone losers. Relevance to the management of osteoporosis
/
|
21 |
Diseases of the musculoskeletal system
/
|
22 |
Drug treatment of osteoporosis
/
|
23 |
Combined calcium and vitamin D supplementation reduces bone loss and fracture incidence in older men and women
/
DOI ScienceOn |
24 |
Bone density and fracture risk in man
/
DOI ScienceOn |
25 |
Does <TEX>$1,25(OH)_2D_3$</TEX> accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women
/
|
26 |
Calcium and vitamin D in osteoporosis
/
DOI ScienceOn |
27 |
Congenital defects of the dog
/
|
28 |
Adjuvant disease in rats : biochemical criteria for distinguishing several phases of inflammation and arthritis
/
DOI |
29 |
Therapeutic efficacy of 1α,25-dihydroxyvitamin <TEX>$D_3$</TEX>and calcium in osteopenic ovariectomized rats : evidence for a direct anabolic effects of 1α,25-dihydroxyvitamin <TEX>$D_3$</TEX> on bone
/
DOI ScienceOn |
30 |
Vitamin D and bone health
/
|
31 |
Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women
/
DOI ScienceOn |
32 |
Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatiod arthritis
/
|
33 |
Sex hormone status and bone metabolism in men with Crohn's disease
/
DOI ScienceOn |
34 |
Decreased T-suppressor cell activity in rats with adjuvant arthritis
/
DOI ScienceOn |
35 |
Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats
/
DOI ScienceOn |
36 |
1α,25-dihydroxyvitamin <TEX>$D_3$</TEX> induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria
/
DOI |
37 |
Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study
/
DOI ScienceOn |
38 |
Effects of 1,25 dihydroxyvitamin <TEX>$D_3$</TEX> and calcitonin on fracture healing in adult rats
/
|
39 |
Changes in bone mineral density in rat adjuvant arthritis
/
DOI ScienceOn |
40 |
Rationale for active vitamin D analog therapy in senile osteoporosis
/
DOI ScienceOn |
41 |
Osteoporosis in men
/
|
42 |
Calcitriol and bone mass accumulation in females during puberty
/
DOI ScienceOn |
43 |
The role of parathyroid hormone in the pathogenesis, prevention and treatment of postmenopausal osteoporosis
/
|
44 |
Bisphosphonate therapy
/
DOI ScienceOn |
45 |
1,25-dihydroxyvitamin D3: Short- and long-term effects on bone and calcium metabolism in parients with postmenopausal osteoporosis
/
DOI ScienceOn |
46 |
Secondary osteoporosis
/
|
47 |
Vitamin D metabolism and its clinical application
/
|
48 |
Osteoporosis : intervention options
/
DOI ScienceOn |
49 |
Effect of 1,25-dihydroxyvitamin <TEX>$D_3$</TEX> in itself or combined with hormone treatment in preventing postmenopausal osteoporosis
/
DOI ScienceOn |
50 |
Metabolism of vitamin D : current status
/
|
51 |
Homocyst(e)inaemia and bone density in elderly women
/
|
52 |
Secondary osteoporosis and its treatment-diabetes mellitus
/
|